Emeryville, CA
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases.
kyvernatx.comThese are collections Kyverna Therapeutics is a part of. Click on the collection name to view similar companies.
IPO
Unknown
Series B
$60,000,000
Series B
$85,000,000
Series A
$25,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Kyverna Therapeutics.